• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dare Bioscience Inc (NQ: DARE )

    0.2800 -0.0200 (-6.67%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 555,803
    Open 0.2900
    Bid (Size) 0.2801 (88)
    Ask (Size) 0.2899 (20)
    Prev. Close 0.3000
    Today's Range 0.2800 - 0.3100
    52wk Range 0.2700 - 1.100
    Shares Outstanding 70,521,979
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga

    Performance

    YTD
    -14.87%
    -14.87%
    1 Month
    -39.51%
    -39.51%
    3 Month
    -9.68%
    -9.68%
    6 Month
    -39.59%
    -39.59%
    1 Year
    -72.00%
    -72.00%

    More News

    Read More
    DARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Recap: Dare Bioscience Q4 Earnings
    Via Benzinga
    Dare Bioscience Earnings Preview
    Via Benzinga
    First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
    Via Benzinga
    Earnings Outlook For Dare Bioscience
    Via Benzinga
    Earnings Outlook For Dare Bioscience
    Via Benzinga
    Recap: Dare Bioscience Q1 Earnings
    Via Benzinga
    Earnings Scheduled For March 28, 2024
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Earnings Outlook For Dare Bioscience
    Via Benzinga
    Earnings Preview: Dare Bioscience
    Via Benzinga
    Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful Menstruation
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Daré Bioscience Shares Move Higher Intravaginal Ring Shows Promise In Menopause Symptoms
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.